BRIEF-UK's CMA Announces Start Of Merger Investigation Into Global Payments / Worldpay Deal-March 2024-www.financetom.com

BRIEF-UK's CMA Announces Start Of Merger Investigation Into Global Payments / Worldpay Deal

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BRIEF-UK's CMA Announces Start Of Merger Investigation Into Global Payments / Worldpay Deal

Sep 16, 2025 5:53 AM

Sept 16 (Reuters) - UK's CMA:

* COMPETITION AND MKTS - MERGER UPDATE: GLOBAL PAYMENTS ( GPN ) /

WORLDPAY

* UK'S CMA: START OF CMA MERGER INVESTIGATION: GLOBAL

PAYMENTS ( GPN ) /

WORLDPAY MERGER INQUIRY

* UK'S CMA: DEADLINE OF 11 NOVEMBER 2025 FOR ITS PHASE 1

DECISION

ON GLOBAL PAYMENTS / WORLDPAY MERGER INQUIRY

Source text:

Further company coverage:

Previous page： Nvidia Insider Sold Shares Worth $170,020,366, According to a Recent SEC Filing Next page： BRIEF-Jyong Biotech Files For Us IPO

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Nvidia Insider Sold Shares Worth $170,020,366, According to a Recent SEC Filing

Mar 7, 2024

06:48 AM EST, 03/07/2024 (MT Newswires) -- Tench Coxe, Director, on March 05, 2024, sold 200,000 shares in Nvidia ( NVDA ) for $170,020,366. Following the Form 4 filing with the SEC, Coxe has control over a total of 3,787,612 shares of the company, with 5,228 shares held directly and 3,782,384 shares controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1045810/000122520824003814/xslF345X03/doc4.xml ...

BRIEF-Jyong Biotech Files For Us IPO

Mar 7, 2024

March 7 (Reuters) - * JYONG BIOTECH LTD. FILES FOR US IPO * JYONG BIOTECH LTD.: JOSEPH STONE CAPITAL, LLC WILL BE UNDERWRITER FOR IPO Source text for Eikon: ...

GSK Reports Positive Results From Interim Analysis of Test of Potential Blood Cancer Treatment -- Shares Up Pre-Bell

Mar 7, 2024

06:51 AM EST, 03/07/2024 (MT Newswires) -- GSK (GSK) said Thursday that it had received positive results from an interim analysis of a late-stage study of its potential multiple myeloma treatment Blenrep in combination with pomalidomide plus dexamethasone compared with bortezomib plus dexamethasone. The company said the trial, involving 302 patients, met its primary endpoint of progression-free survival at a...

Bilibili's Q4 Adjusted Loss Narrows, Revenue Increases

Mar 7, 2024

06:47 AM EST, 03/07/2024 (MT Newswires) -- Bilibili ( BILI ) posted a Q4 adjusted loss Thursday of 1.34 Chinese renminbi ($0.19) per diluted American depositary share, compared with a loss of 3.31 renminbi a year earlier. Analysts polled by Capital IQ expected an adjusted loss of 1.57 renminbi. Revenue for the quarter ended Dec. 31 was 6.35 billion renminbi,...